In ovarian cancer, a common mechanism for resistance to the taxane paclitaxel and other chemotherapy agents is overexpression of ATP-dependent efflux pumps, especially Multidrug Resistance Protein 1 (MDR1)/P-glycoprotein/ABCB1. Here, ABCB1 is linked to ovarian carcinoma.